Endiya Partners has closed its Rs 500 crore ($75 million) second venture capital fund with a commitment from a biotechnology fund backed by the government’s Biotechnology Industry Research Assistance Council (BIRAC), it said on January 4.
The Biotechnology Innovation Fund - AcE(Accelerating Entrepreneurs) Fund is a fund-of-funds investing in biotech startups and VC funds in the space, and has invested $2.5 million in Endiya
Endiya’s portfolio companies include Binny Bansal-backed diagnostics startup SigTuple and Darwinbox- which makes Human Resources systems in companies more efficient.
“Our focus continues to be on the enterprise software and business-to-business space along with healthcare technology- all of which have become more crucial in the post pandemic era,” said Dr Ramesh Byrapaneni, Managing Director at Endiya.
“BIRAC’s investment gives both of us a common alignment to find the right startups and work towards a common cause. They can also connect us to other entrepreneurs and experts in the biotech space.
Cardiologist-turned investor Byrapaneni started Endiya along with Sateesh Andra and Abhishek Srivastava in 2016. Endiya raised a debut Rs 175 crore fund in 2017 which it has fully deployed. It hit a first close of $40 million for the second fund in May 2019.
Investors in Endiya’s current fund include the International Finance Corporation and the Nippon India Digital Innovation fund- an India-Japan initiative. Nippon is one of Japan’s largest life insurance players.
From the second fund, Endiya plans to make 18-20 investments of about $1 million each, with more money in follow-on rounds.
Endiya’s focus on the enterprise software space also comes at a time when software-as-a-service startups have been attracting rich valuations at aggressive multiples in public and private markets.
2020 saw two Indian SaaS unicorns- Zenoti and Postman- both valued at over a billion dollars each.
In addition, successful IPOs for software firm CloudFlare, Zoom’s share price skyrocketing and Slack being acquired for $27.7 billion by Salesforce further bolsters the environment.
“In the US, a B2B SaaS correction needs to happen. It has been a bit too exuberant. But these companies have the ability to gain a large market share soon and almost become a monopoly, while not burning cash. There have also been large mergers and acquisitions, boosting the space even more,” said Sateesh Andra, managing director at Endiya.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
